|
Evogene to receive $3.5 million payment related to patent portfolio under its existing seed traits collaboration with Bayer
Rehovot, Israel
December 8, 2022
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Bayer will pay Evogene an amount of $3.5 million under their joint seed traits collaboration agreement.
Under the collaboration agreement, Evogene provided Bayer with a license to genes discovered to address specific seed traits, for use in corn, soy, cotton, and canola. The payment is part of a restructuring of the patent filing, prosecution, and maintenance obligations under the collaboration.
More news from:
. Evogene Ltd.
. Bayer CropScience AG
Website: http://www.evogene.com Published: December 8, 2022 |
|
The news item on this page is copyright by the organization where it originated
Fair use notice |
Topics
Species
